Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +735.17%
#3 ADO Protocol ADO Protocol +101.50%
#4 Cortex Cortex +93.33%
#5 Ontology Gas Ontology Gas +70.29%
#6 Kinesis Silver Kinesis Silver +53.19%
#7 Magma Finance Magma Finance +29.14%
#8 OpenEden OpenEden +28.14%
#9 PondCoin PondCoin +25.66%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Flerie AB (publ) Flerie AB (publ)

Flerie AB (publ)

FLERIE
Clasificación en acciones #18881
Flerie AB (publ) functions as a venture capital entity, concentrating its... Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
Precio por acción
$2.11
Capitalización bursátil
$183.02M
Cambio (1 día)
-1.82%
Cambio (1 año)
-45.27%
País
SE
Comercio Flerie AB (publ) (FLERIE)

Categoría

Healthcare
Ganancias de Flerie AB (publ) (FLERIE)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Flerie AB (publ), gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Flerie AB (publ) desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US